Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Smooth, Vascular | 5 | 2019 | 130 | 0.940 |
Why?
|
| Histone Deacetylases | 2 | 2020 | 56 | 0.890 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2020 | 37 | 0.830 |
Why?
|
| Signal Transduction | 4 | 2020 | 1908 | 0.680 |
Why?
|
| Ethers | 1 | 2016 | 20 | 0.540 |
Why?
|
| Butyrates | 3 | 2019 | 31 | 0.500 |
Why?
|
| Neoplasms | 1 | 2020 | 1103 | 0.370 |
Why?
|
| Butyric Acid | 2 | 2007 | 18 | 0.370 |
Why?
|
| Acrolein | 2 | 2017 | 16 | 0.360 |
Why?
|
| Glutathione Transferase | 2 | 2007 | 88 | 0.360 |
Why?
|
| Glutathione | 1 | 2007 | 179 | 0.280 |
Why?
|
| Cell Proliferation | 3 | 2019 | 1198 | 0.250 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2019 | 86 | 0.240 |
Why?
|
| Antioxidants | 1 | 2007 | 416 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 136 | 0.210 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 1015 | 0.200 |
Why?
|
| Protein Binding | 3 | 2020 | 972 | 0.190 |
Why?
|
| Animals | 11 | 2020 | 15081 | 0.190 |
Why?
|
| Morpholines | 1 | 2020 | 69 | 0.180 |
Why?
|
| Pyrimidines | 1 | 2020 | 118 | 0.180 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 65 | 0.170 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 122 | 0.170 |
Why?
|
| Drug Discovery | 1 | 2020 | 82 | 0.170 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2018 | 2 | 0.160 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 219 | 0.160 |
Why?
|
| Rats | 6 | 2019 | 3483 | 0.160 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2018 | 41 | 0.150 |
Why?
|
| PPAR alpha | 1 | 2018 | 42 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 84 | 0.150 |
Why?
|
| Receptors, Immunologic | 1 | 2017 | 61 | 0.140 |
Why?
|
| PPAR gamma | 1 | 2017 | 53 | 0.140 |
Why?
|
| Allosteric Regulation | 1 | 2016 | 22 | 0.140 |
Why?
|
| Computer-Aided Design | 1 | 2016 | 11 | 0.140 |
Why?
|
| Apoptosis | 2 | 2020 | 1398 | 0.130 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2016 | 83 | 0.130 |
Why?
|
| Molecular Conformation | 1 | 2016 | 152 | 0.130 |
Why?
|
| Exosomes | 1 | 2017 | 101 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 409 | 0.130 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2016 | 107 | 0.120 |
Why?
|
| Mice | 3 | 2020 | 5913 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 803 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2007 | 461 | 0.110 |
Why?
|
| Aorta | 2 | 2003 | 167 | 0.100 |
Why?
|
| Inflammation | 1 | 2017 | 618 | 0.100 |
Why?
|
| Down-Regulation | 3 | 2018 | 435 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2017 | 426 | 0.100 |
Why?
|
| Exercise | 1 | 2017 | 613 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2019 | 1518 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 664 | 0.090 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 173 | 0.090 |
Why?
|
| Histones | 1 | 2010 | 190 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2010 | 229 | 0.080 |
Why?
|
| DNA Primers | 1 | 2007 | 286 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2010 | 513 | 0.070 |
Why?
|
| Base Sequence | 1 | 2007 | 997 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2010 | 928 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2018 | 933 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2003 | 69 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 59 | 0.060 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2004 | 28 | 0.060 |
Why?
|
| Blotting, Northern | 1 | 2003 | 150 | 0.060 |
Why?
|
| Sodium | 1 | 2004 | 103 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2003 | 191 | 0.060 |
Why?
|
| Cell Division | 1 | 2003 | 307 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 306 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2002 | 95 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2002 | 77 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 103 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2002 | 100 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 99 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 623 | 0.050 |
Why?
|
| RNA | 1 | 2003 | 241 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2002 | 444 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2004 | 316 | 0.050 |
Why?
|
| Humans | 3 | 2020 | 37093 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2004 | 1618 | 0.050 |
Why?
|
| DNA | 1 | 2003 | 574 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2020 | 109 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2003 | 1207 | 0.040 |
Why?
|
| Time Factors | 1 | 2003 | 1742 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2004 | 681 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 349 | 0.040 |
Why?
|
| Diuresis | 1 | 2018 | 7 | 0.040 |
Why?
|
| Kidney Cortex | 1 | 2018 | 8 | 0.040 |
Why?
|
| Kidney Medulla | 1 | 2018 | 6 | 0.040 |
Why?
|
| Natriuresis | 1 | 2018 | 11 | 0.040 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2018 | 30 | 0.040 |
Why?
|
| Ribose | 1 | 2017 | 11 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2018 | 128 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2017 | 15 | 0.040 |
Why?
|
| Phosphates | 1 | 2017 | 51 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 269 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2002 | 938 | 0.040 |
Why?
|
| Neurons | 1 | 2003 | 1175 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2020 | 808 | 0.030 |
Why?
|
| RNA Interference | 1 | 2017 | 243 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2017 | 109 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1609 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2010 | 27 | 0.020 |
Why?
|
| Cyclins | 1 | 2010 | 37 | 0.020 |
Why?
|
| G1 Phase | 1 | 2010 | 33 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 27 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2010 | 55 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 98 | 0.020 |
Why?
|
| Methylation | 1 | 2010 | 113 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 172 | 0.020 |
Why?
|
| Mitosis | 1 | 2010 | 99 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 169 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2010 | 134 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 326 | 0.020 |
Why?
|
| Acyl-CoA Dehydrogenase | 1 | 2004 | 5 | 0.020 |
Why?
|
| Clofibrate | 1 | 2004 | 13 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2004 | 36 | 0.010 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2004 | 28 | 0.010 |
Why?
|
| Nitrates | 1 | 2004 | 40 | 0.010 |
Why?
|
| Male | 2 | 2018 | 20025 | 0.010 |
Why?
|
| Biological Transport | 1 | 2004 | 185 | 0.010 |
Why?
|
| Female | 1 | 2018 | 20969 | 0.010 |
Why?
|